AuditorJul 17, 2026, 07:21 AM
GSK Re-appoints Deloitte as External Auditor from 2028
AI Summary
GSK plc announced the re-appointment of Deloitte LLP as its external auditor, effective from the financial year ending December 31, 2028. This decision follows a competitive tender process conducted by the Audit & Risk Committee. As a Public Interest Entity, GSK is required to tender its statutory audit every 10 years and rotate every 20 years, with Deloitte initially appointed in 2018. The re-appointment will be subject to shareholder approval at the company's 2028 Annual General Meeting.
Key Highlights
- GSK re-appointed Deloitte LLP as its external auditor.
- The re-appointment is effective from the financial year ending December 31, 2028.
- The decision followed a competitive tender process led by the Audit & Risk Committee.
- GSK, as a Public Interest Entity, must tender its statutory audit every 10 years and rotate every 20 years.
- Deloitte was initially appointed as external auditor from the financial year ended December 31, 2018.
- Shareholder approval for Deloitte's re-appointment will be sought at the 2028 Annual General Meeting.
Price Impact
More from GSK